T&L Co. Ltd (340570) - Total Assets
Based on the latest financial reports, T&L Co. Ltd (340570) holds total assets worth ₩219.17 Billion KRW (≈ $148.53 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
T&L Co. Ltd - Total Assets Trend (2017–2024)
This chart illustrates how T&L Co. Ltd's total assets have evolved over time, based on quarterly financial data. Also see T&L Co. Ltd (340570) market capitalisation for the company's overall valuation and market capitalisation.
T&L Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
T&L Co. Ltd's total assets of ₩219.17 Billion consist of 58.0% current assets and 42.0% non-current assets. Review T&L Co. Ltd (340570) total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩60.66 Billion | 30.8% |
| Accounts Receivable | ₩16.27 Billion | 8.3% |
| Inventory | ₩19.70 Billion | 10.0% |
| Property, Plant & Equipment | ₩74.89 Billion | 38.0% |
| Intangible Assets | ₩3.64 Billion | 1.9% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how T&L Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 340570 stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: T&L Co. Ltd's current assets represent 58.0% of total assets in 2024, an increase from 30.6% in 2017.
- Cash Position: Cash and equivalents constituted 30.8% of total assets in 2024, up from 0.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 3.0% in 2017.
- Asset Diversification: The largest asset category is property, plant & equipment at 38.0% of total assets.
T&L Co. Ltd Competitors by Total Assets
Key competitors of T&L Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medtronic plc
SA:MDTC34
|
Brazil | R$93.03 Billion |
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Biosynex
PA:ALBIO
|
France | €149.44 Million |
T&L Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.65 | 5.50 | 7.57 |
| Quick Ratio | 6.63 | 4.58 | 6.75 |
| Cash Ratio | 0.00 | 0.88 | 0.00 |
| Working Capital | ₩113.26 Billion | ₩85.76 Billion | ₩41.30 Billion |
T&L Co. Ltd - Advanced Valuation Insights
This section examines the relationship between T&L Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.04 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 38.7% |
| Total Assets | ₩197.08 Billion |
| Market Capitalization | $147.57 Million USD |
Valuation Analysis
Below Book Valuation: The market values T&L Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: T&L Co. Ltd's assets grew by 38.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for T&L Co. Ltd (2017–2024)
The table below shows the annual total assets of T&L Co. Ltd from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩197.08 Billion ≈ $133.56 Million |
+38.68% |
| 2023-12-31 | ₩142.11 Billion ≈ $96.30 Million |
+21.46% |
| 2022-12-31 | ₩117.00 Billion ≈ $79.29 Million |
+19.01% |
| 2021-12-31 | ₩98.31 Billion ≈ $66.62 Million |
+23.73% |
| 2020-12-31 | ₩79.45 Billion ≈ $53.84 Million |
+83.42% |
| 2019-12-31 | ₩43.32 Billion ≈ $29.36 Million |
+18.58% |
| 2018-12-31 | ₩36.53 Billion ≈ $24.76 Million |
+8.82% |
| 2017-12-31 | ₩33.57 Billion ≈ $22.75 Million |
-- |
About T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more